M.C. Garassino
About
In The Last Decade
M.C. Garassino
12 papers receiving 363 citations
Peers
Comparison fields: 5 of 38
- Pulmonary and Respiratory Medicine 327
- Oncology 267
- Cancer Research 90
- Molecular Biology 71
- Surgery 16
Countries citing papers authored by M.C. Garassino
This map shows the geographic impact of M.C. Garassino's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M.C. Garassino with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M.C. Garassino more than expected).
Fields of papers citing papers by M.C. Garassino
This network shows the impact of papers produced by M.C. Garassino. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M.C. Garassino. The network helps show where M.C. Garassino may publish in the future.
Co-authorship network of co-authors of M.C. Garassino
This figure shows the co-authorship network connecting the top 25 collaborators of M.C. Garassino. A scholar is included among the top collaborators of M.C. Garassino based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M.C. Garassino. M.C. Garassino is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 3 | |
| 3 | 11 | |
| 4 | 3 | |
| 5 | 1 | |
| 6 | 19 | |
| 7 | 1 | |
| 8 | 3 | |
| 9 | 23 | |
| 10 | 4 | |
| 11 | 8 | |
| 12 | Osimertinib or platinum–pemetrexed in EGFR T790M–positive lung cancer | 290 |
| 13 | 1 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.